Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$10.77 USD
-0.27 (-2.45%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $10.78 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, ORTHOFIX MEDICAL INC. has a PEG ratio of 18.40 compared to the Medical - Instruments industry's PEG ratio of 2.25.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OFIX 10.77 -0.27(-2.45%)
Will OFIX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OFIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OFIX
Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates
OFIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings
Orthofix (OFIX) Q4 Earnings Lag Estimates
Other News for OFIX
Rewey Asset Management Q2 2025 Investment Letter
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference | OFIX Stock News
Orthofix to Report Second Quarter 2025 Financial Results | OFIX Stock News
Orthofix (OFIX) Receives Outperform Rating with Promising Growth Outlook | OFIX Stock News
Orthofix initiated with an Outperform at Barrington